Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer

Cell Reports

Volumn 10, Issue 4, 2015, Pages 562-573

  Sagiv, Jitka Y ^a   Michaeli, Janna ^b   Assi, Simaan ^a   Mishalian, Inbal ^b   Kisos, Hen ^a   Levy, Liran ^b   Damti, Pazzit ^b   Lumbroso, Delphine ^c   Polyansky, Lola ^a   Sionov, Ronit V ^a   Ariel, Amiram ^c   Hovav, Avi Hai ^d   Henke, Erik ^e   Fridlender, Zvi G ^b   Granot, Zvi ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c UNIVERSITY OF HAIFA   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; CELL SUBPOPULATION; CONTROLLED STUDY; EX VIVO STUDY; HIGH DENSITY NEUTROPHIL; HUMAN; HUMAN CELL; INFLAMMATION; LOW DENSITY NEUTROPHIL; LUNG CANCER; MESOTHELIOMA; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NEOPLASM; NEUTROPHIL; NONHUMAN; PERITONITIS; PHENOTYPIC PLASTICITY; PHENOTYPIC VARIATION; SUPPRESSOR CELL; TUMOR GROWTH; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; CELL LINE; CYTOLOGY; IMMUNOLOGY; PATHOLOGY;

ANIMALS; CELL LINE; CELLS, CULTURED; HUMANS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASMS; NEUTROPHILS;

EID: 84922777488     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.12.039     Document Type: Article

References (47)

1. Ackermann M.F., Lamm K.R., Wiegand G.W., Luster M.I. Antitumor activity of murine neutrophils demonstrated by cytometric analysis. Cancer Res. 1989, 49:528-532.
2. Bannenberg G.L., Chiang N., Ariel A., Arita M., Tjonahen E., Gotlinger K.H., Hong S., Serhan C.N. Molecular circuits of resolution: formation and actions of resolvins and protectins. J.Immunol. 2005, 174:4345-4355.
3. Barcellos-Hoff M.H., Akhurst R.J. Transforming growth factor-beta in breast cancer: too much, too late. Breast Cancer Res. 2009, 11:202.
4. Beauvillain C., Cunin P., Doni A., Scotet M., Jaillon S., Loiry M.L., Magistrelli G., Masternak K., Chevailler A., Delneste Y., Jeannin P. CCR7 is involved in the migration of neutrophils to lymph nodes. Blood 2011, 117:1196-1204.
5. Borregaard N., Kjeldsen L., Sengeløv H., Diamond M.S., Springer T.A., Anderson H.C., Kishimoto T.K., Bainton D.F. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J.Leukoc. Biol. 1994, 56:80-87.
6. Brandau S., Trellakis S., Bruderek K., Schmaltz D., Steller G., Elian M., Suttmann H., Schenck M., Welling J., Zabel P., Lang S. Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties. J.Leukoc. Biol. 2011, 89:311-317.
7. Cloke T., Munder M., Taylor G., Müller I., Kropf P. Characterization of a novel population of low-density granulocytes associated with disease severity in HIV-1 infection. PLoS ONE 2012, 7:e48939.
8. Colombo M.P., Lombardi L., Stoppacciaro A., Melani C., Parenza M., Bottazzi B., Parmiani G. Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition invivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cells. J.Immunol. 1992, 149:113-119.
9. Cretney E., Takeda K., Yagita H., Glaccum M., Peschon J.J., Smyth M.J. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J.Immunol. 2002, 168:1356-1361.
10. De Larco J.E., Wuertz B.R., Furcht L.T. The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin. Cancer Res. 2004, 10:4895-4900.
11. Denny M.F., Yalavarthi S., Zhao W., Thacker S.G., Anderson M., Sandy A.R., McCune W.J., Kaplan M.J. A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs. J.Immunol. 2010, 184:3284-3297.
12. Di Carlo E., Forni G., Lollini P., Colombo M.P., Modesti A., Musiani P. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 2001, 97:339-345.
13. Dumitru C.A., Moses K., Trellakis S., Lang S., Brandau S. Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology. Cancer Immunol. Immunother. 2012, 61:1155-1167.
14. Fridlender Z.G., Albelda S.M. Tumor-associated neutrophils: friend or foe?. Carcinogenesis 2012, 33:949-955.
15. Fridlender Z.G., Sun J., Kim S., Kapoor V., Cheng G., Ling L., Worthen G.S., Albelda S.M. Polarization of tumor-associated neutrophil phenotype by TGF-beta: "N1" versus "N2" TAN. Cancer Cell 2009, 16:183-194.
16. Galdiero M.R., Bonavita E., Barajon I., Garlanda C., Mantovani A., Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology 2013, 218:1402-1410.
17. Galli S.J., Borregaard N., Wynn T.A. Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat. Immunol. 2011, 12:1035-1044.
18. Granot Z., Henke E., Comen E.A., King T.A., Norton L., Benezra R. Tumor entrained neutrophils inhibit seeding in the premetastatic lung. Cancer Cell 2011, 20:300-314.
19. Heifets L. Centennial of Metchnikoff's discovery. J.Reticuloendothel. Soc. 1982, 31:381-391.
20. Henson P.M., Bratton D.L. Antiinflammatory effects of apoptotic cells. J.Clin. Invest. 2013, 123:2773-2774.
21. Hicks A.M., Riedlinger G., Willingham M.C., Alexander-Miller M.A., Von Kap-Herr C., Pettenati M.J., Sanders A.M., Weir H.M., Du W., Kim J., et al. Transferable anticancer innate immunity in spontaneous regression/complete resistance mice. Proc. Natl. Acad. Sci. USA 2006, 103:7753-7758.
22. Jan M.S., Huang Y.H., Shieh B., Teng R.H., Yan Y.P., Lee Y.T., Liao K.K., Li C. CC chemokines induce neutrophils to chemotaxis, degranulation, and alpha-defensin release. J.Acquir. Immune Defic. Syndr. 2006, 41:6-16.
23. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat. Rev. Cancer 2009, 9:239-252.
24. Kowanetz M., Wu X., Lee J., Tan M., Hagenbeek T., Qu X., Yu L., Ross J., Korsisaari N., Cao T., et al. Granulocyte-colony stimulating factor promotes lung metastasis through mobilization of Ly6G+Ly6C+ granulocytes. Proc. Natl. Acad. Sci. USA 2010, 107:21248-21255.
25. Kushner B.H., Cheung N.K. Absolute requirement of CD11/CD18 adhesion molecules, FcRII and the phosphatidylinositol-linked FcRIII for monoclonal antibody-mediated neutrophil antihuman tumor cytotoxicity. Blood 1992, 79:1484-1490.
26. López-Lago M.A., Posner S., Thodima V.J., Molina A.M., Motzer R.J., Chaganti R.S. Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression. Oncogene 2013, 32:1752-1760.
27. Mantovani A., Cassatella M.A., Costantini C., Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 2011, 11:519-531.
28. Mayadas T.N., Cullere X., Lowell C.A. The multifaceted functions of neutrophils. Annu. Rev. Pathol. 2014, 9:181-218.
29. McGary C.T., Miele M.E., Welch D.R. Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity. Am. J. Pathol. 1995, 147:1668-1681.
30. Mishalian I., Bayuh R., Levy L., Zolotarov L., Michaeli J., Fridlender Z.G. Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression. Cancer Immunol. Immunother. 2013, 62:1745-1756.
31. Morisaki T., Goya T., Ishimitsu T., Torisu M. The increase of low density subpopulations and CD10 (CALLA) negative neutrophils in severely infected patients. Surg. Today 1992, 22:322-327.
32. Novitskiy S.V., Pickup M.W., Chytil A., Polosukhina D., Owens P., Moses H.L. Deletion of TGF-β signaling in myeloid cells enhances their anti-tumorigenic properties. J.Leukoc. Biol. 2012, 92:641-651.
33. Nozawa H., Chiu C., Hanahan D. Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis. Proc. Natl. Acad. Sci. USA 2006, 103:12493-12498.
34. Pekarek L.A., Starr B.A., Toledano A.Y., Schreiber H. Inhibition of tumor growth by elimination of granulocytes. J.Exp. Med. 1995, 181:435-440.
35. Peranzoni E., Zilio S., Marigo I., Dolcetti L., Zanovello P., Mandruzzato S., Bronte V. Myeloid-derived suppressor cell heterogeneity and subset definition. Curr. Opin. Immunol. 2010, 22:238-244.
36. Piccard H., Muschel R.J., Opdenakker G. On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit. Rev. Oncol. Hematol. 2012, 82:296-309.
37. Schif-Zuck S., Gross N., Assi S., Rostoker R., Serhan C.N., Ariel A. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 2011, 41:366-379.
38. Schmidt H., Bastholt L., Geertsen P., Christensen I.J., Larsen S., Gehl J., von der Maase H. Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br. J. Cancer 2005, 93:273-278.
39. Shen L., Smith J.M., Shen Z., Eriksson M., Sentman C., Wira C.R. Inhibition of human neutrophil degranulation by transforming growth factor-beta1. Clin. Exp. Immunol. 2007, 149:155-161.
40. Sionov R.V., Fridlender Z.G., Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron. 2014, Published online June 4, 2014. 10.1007/s12307-014-0147-5.
41. Solito S., Marigo I., Pinton L., Damuzzo V., Mandruzzato S., Bronte V. Myeloid-derived suppressor cell heterogeneity in human cancers. Ann. N Y Acad. Sci. 2014, 1319:47-65.
42. Tsuda Y., Takahashi H., Kobayashi M., Hanafusa T., Herndon D.N., Suzuki F. Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 2004, 21:215-226.
43. Waight J.D., Hu Q., Miller A., Liu S., Abrams S.I. Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloid-derived suppressor cell-dependent mechanism. PLoS ONE 2011, 6:e27690.
44. Welch D.R., Schissel D.J., Howrey R.P., Aeed P.A. Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc. Natl. Acad. Sci. USA 1989, 86:5859-5863.
45. Wilderman M.J., Sun J., Jassar A.S., Kapoor V., Khan M., Vachani A., Suzuki E., Kinniry P.A., Sterman D.H., Kaiser L.R., Albelda S.M. Intrapulmonary IFN-beta gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung. Cancer Res. 2005, 65:8379-8387.
46. Youn J.I., Nagaraj S., Collazo M., Gabrilovich D.I. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J.Immunol. 2008, 181:5791-5802.
47. Zhu B., Bando Y., Xiao S., Yang K., Anderson A.C., Kuchroo V.K., Khoury S.J. CD11b+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J.Immunol. 2007, 179:5228-5237.